Urology Times Newsletter

MEN’S HEALTH MONDAY

Protocol cuts narcotic use in IPP patients

Researchers studying a novel multimodal analgesia protocol at multiple institutions in the U.S. for patients having penile implant surgery found narcotic prescriptions before, during, and in the post-surgery recovery period fell from as high as 50 to 60 narcotic pills to 10 to 15 pills.

Learn more

Video: Study will test targeted PCa therapies based on genomic alterations

Martin Gleave, MD, of the University of British Columbia in Vancouver, discusses the Genomic Umbrella Neoadjuvant Study (GUNS) trial, which uses a multi-arm, multistage adaptive design to test targeted therapies in patients with high-risk localized disease by matching neoadjuvant therapies to baseline genomic alterations.

Watch the video

Study compares prostate cancer treatment functional outcomes

"Irrespective of treatment, fewer than half of men reported the ability to maintain erections sufficient for intercourse at 5 years," writes Badar M. Mian, MD.

Read his column

SURVEY

Is DRE still a relevant tool in the management of prostate cancer?